HIGHLIGHTS
- who: Philipp Krausewitz et al. from the Department of Urology and Pediatric Urology, University Hospital Bonn, Bonn, Germany have published the research: Early Dynamics of Quantitative SEPT9 and SHOX2 Methylation in Circulating Cell-Free Plasma DNA during Prostate Biopsy for Prostate Cancer Diagnosis, in the Journal: Cancers 2022, 4355 of 12/Oct/2020
- what: The present proof-of-concept study aimed to investigate the potential and dynamics of quantitative SEPT9 and SHOX2 methylation in_(PCa) patient tissue and ccfDNA during biopsy as a diagnostic tool. Despite this, the authors believe that the study provided clinically . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.